Literature DB >> 12407572

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

.   

Abstract

Mesh：

Year:  2002        PMID： 12407572     DOI： 10.1053/jhep.2002.37117

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  211 in total

1.  Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis.

Authors:  Naoki Fujita; Mamoru Nakanishi; Jun Mukai; Yuuji Naito; Takafumi Ichida; Masahiko Kaito; Toshikazu Yoshikawa; Yoshiyuki Takei
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

2.  Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin.

Authors:  María Trapero-Marugán; Jorge Mendoza; María Chaparro; Leticia González-Moreno; José Andrés Moreno-Monteagudo; María Jesús Borque; Ricardo Moreno-Otero
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

3.  Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.

Authors:  K A Forde; K Haynes; A B Troxel; S Trooskin; M T Osterman; S E Kimmel; J D Lewis; V Lo Re
Journal:  J Viral Hepat       Date:  2011-11-13       Impact factor: 3.728

4.  Hematopoietic growth factors for acute myelogenous leukemia.

Authors:  Matt Kalaycio
Journal:  Curr Hematol Rep       Date:  2004-01

Review 5.  Treatment of hepatitis C. The 2002 French consensus.

Authors:  D Dhumeaux; P Marcellin; E Lerebours
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

Review 6.  [Bioptic diagnosis of chronic hepatitis. Results of an evidence-based consensus conference of the German Society of Pathology, of the German Society for Digestive and Metabolic Diseases and of Compensated Hepatitis (HepNet)].

Authors:  P Schirmacher; W E Fleig; A Tannapfel; C Langner; V Dries; L Terracciano; H Denk; H P Dienes
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

7.  Treatment of interferon non-responsive chronic hepatitis C with triple therapy with interferon, ribavirin, and amantidine can be encouraging.

Authors:  N Khokhar
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

8.  Acoustic radiation force impulse quantification: repeatability of measurements in selected liver segments and influence of age, body mass index and liver capsule-to-box distance.

Authors:  O S Jaffer; P F C Lung; D Bosanac; V M Patel; S M Ryan; M A Heneghan; A Quaglia; P S Sidhu
Journal:  Br J Radiol       Date:  2012-07-04       Impact factor: 3.039

9.  Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.

Authors:  Harel Dahari; Stephen M Feinstone; Marian E Major
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

10.  Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage.

Authors:  Romain Moirand; Marc Bilodeau; Suzanne Brissette; Julie Bruneau
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.